Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.
about
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expressionSambucus nigra extracts inhibit infectious bronchitis virus at an early point during replicationAntisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growthLicorice beta-amyrin 11-oxidase, a cytochrome P450 with a key role in the biosynthesis of the triterpene sweetener glycyrrhizinRespiratory viruses other than influenza virus: impact and therapeutic advancesManagement of Critically Ill Patients with Severe Acute Respiratory Syndrome (SARS)Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plantsGlycyrrhizic acid in the treatment of liver diseases: literature reviewHuman coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategiesThe broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelopeSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionCoronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeuticsNovel Chemical Ligands to Ebola Virus and Marburg Virus Nucleoproteins Identified by Combining Affinity Mass Spectrometry and Metabolomics ApproachesA review of treatment modalities for Middle East Respiratory Syndrome.Unequivocal glycyrrhizin isomer determination and comparative in vitro bioactivities of root extracts in four Glycyrrhiza speciesMolecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.EST analysis reveals putative genes involved in glycyrrhizin biosynthesisGlycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes.Evaluation of potential anti-toxoplasmosis efficiency of combined traditional herbs in a mouse modelInvolvement of the ERK pathway in the protective effects of glycyrrhizic acid against the MPP+-induced apoptosis of dopaminergic neuronal cells.Molecular model of SARS coronavirus polymerase: implications for biochemical functions and drug designERKs and mitochondria-related pathways are essential for glycyrrhizic acid-mediated neuroprotection against glutamate-induced toxicity in differentiated PC12 cells.Effects of a non-conservative sequence on the properties of β-glucuronidase from Aspergillus terreus Li-20The Effect of Aqueous Extract of Glycyrrhiza glabra on Herpes Simplex Virus 1.Novel inhibitors of severe acute respiratory syndrome coronavirus entry that act by three distinct mechanismsAntioxidant status and immune activity of glycyrrhizin in allergic rhinitis mice.Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling.Ethnoveterinary medicines used for horses in Trinidad and in British Columbia, CanadaApoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition.The effect of spent bleaching earth ageing process on its physicochemical and microbial composition and its potential use as a source of fatty acids and triterpenes.Mechanism of glycyrrhizic acid inhibition of Kaposi's sarcoma-associated herpesvirus: disruption of CTCF-cohesin-mediated RNA polymerase II pausing and sister chromatid cohesion.SARS: pharmacotherapy.SARS--beginning to understand a new virus.Role of interferons in the treatment of severe acute respiratory syndrome.Advancements in the battle against severe acute respiratory syndrome.Antivirals and antiviral strategies.Small molecules targeting severe acute respiratory syndrome human coronavirusNew antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.Current status of anti-SARS agents.
P2860
Q21135459-A7E50A04-BA5D-4140-A448-3421B4B6C600Q21203586-5C43E594-3B98-4486-B138-BFD5C3AFAD4DQ24563538-5AD8EB52-0B7E-4543-A098-03BC45FE3B2EQ24653492-B971BD5B-79C0-4D85-87C0-92F3D4CB87A3Q24655957-31FB3248-CB1C-468A-ADC0-FA80D41C2711Q24791074-E8B77EBD-722A-470A-A3FC-AD5351BEF689Q26769057-23438BE8-2CF4-46EF-8DDE-98658A733D24Q26851465-6D6387BB-643F-4665-96B3-687341A35A92Q27011643-29468729-1876-4FC3-8605-C8AF4CCA0F6CQ27472782-66A401CB-3D2D-4D6E-9F9D-4E84CAD7A0A1Q28383088-94F94552-3EC9-4E50-8B20-2519449236BCQ28535361-CD84D834-2482-414B-915B-3CDC9BB1BA3AQ28830618-38B8C49B-AEE4-42B1-ADC5-D07184A6C7C5Q30248209-6B090B33-0363-46AA-918C-3ABF61A3DABAQ30316767-A9834D65-C37E-481E-94D7-507702AFA301Q33210858-967E3146-A5A5-4C11-8A92-B2BDCA179C53Q33566376-65BC9811-1161-41F4-9931-1EC749799A3CQ33683742-5C6AAA01-77FF-47B8-8032-F468BC386ACEQ33827792-702BA985-51D2-4FCA-9B76-F4067F71272AQ34000309-462F632A-10E9-4C43-9F93-A8068C414534Q34053804-389618EE-4502-4F19-BB09-2C6C11718818Q34083557-DCF020FA-5FB7-4677-996E-24DAEF29BB20Q34162654-CCBB0743-4FBF-4106-8C5B-794A3520A44AQ34437502-3CA11A88-D71E-4106-A323-2AF4125038C1Q34725136-0E6CD4A1-EF53-499D-9B39-3982518C128FQ34874768-96F04AC7-DC1D-43CF-93BC-6FB49F6CE233Q34894092-D69D54F3-E9EE-4D4D-AE91-9B66CAAFF27DQ34980990-20AE3DD8-D68E-4469-B35B-33AC3E749B7DQ35016275-56558653-FCA6-4E95-8853-EFD170A17885Q35137417-C65C0C3C-45A8-4DAE-84AC-E48909147BF8Q35176034-93C1AECE-6F19-4695-BCF6-EC2AEE33D19FQ35363036-3703ACB9-508C-45D4-AF87-C97A61E6510CQ35689787-6DE95F33-C9ED-4093-97D5-9F76564B5917Q35701656-3812E159-0AB4-400B-92B7-0A6F6CAF5F33Q35790834-D50D6E69-10A7-47A0-8DA4-9397095B4A3AQ35841566-52433526-8B70-4EF6-8FDB-7906932E84D0Q35889586-2A98E24B-1AC9-4E64-960F-CB5888AAC6B9Q35970698-C1F91332-A6E5-41F9-9772-5462512E6901Q36058647-194E4C8C-EF3F-404B-963E-ED3E1B76DF1BQ36058652-780FAE02-6108-4FD7-B9EF-8AB96AE7F0DC
P2860
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@en
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@nl
type
label
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@en
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@nl
prefLabel
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@en
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@nl
P2093
P1433
P1476
Glycyrrhizin, an active compon ...... f SARS-associated coronavirus.
@en
P2093
P304
P356
10.1016/S0140-6736(03)13615-X
P407
P577
2003-06-01T00:00:00Z